Performance Comparison of Microfluidic and Immunomagnetic Platforms for Pancreatic CTC Enrichment
November 15, 2025
Brand Name :
Intelence
(United States) [Available]Synonyms :
etravirine
Class :
Antiviral agents and Anti-HIV (antiretroviral)
Dosage Forms & StrengthsÂ
Tablet, Oral:Â
25 mgÂ
100 mgÂ
200 mgÂ
Note: use preferred in combination with other antiretroviral agentsÂ
Dosage Forms & StrengthsÂ
Tablet, Oral:Â
25 mgÂ
100 mgÂ
200 mgÂ
Note: use preferred in combination with other antiretroviral agentsÂ
Refer to adult dosingÂ
It may diminish the levels when combined with efavirenz by enhancing metabolism
It may diminish the effect when combined with irinotecan liposomal by affecting CYP3A4 metabolism
when both drugs are combined, there may be a decreased levels of serum concentration of etravirine   
etravirine decreases the effect of ixazomib by altering intestinal/hepatic CYP3A4 enzyme metabolism
CYP3A strong enhancers of the small intestine may reduce the bioavailability of etravirine
etravirine decreases the effect of entrectinib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
etravirine decreases the effect of encorafenib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
rifabutin: they may diminish the serum concentration of etravirine
it may enhance the metabolism when combined with zuclopenthixol
etravirine: they may diminish the serum concentration of hormonal contraceptive
etravirine: they may diminish the serum concentration of hormonal contraceptive
etravirine: they may diminish the serum concentration of hormonal contraceptive
etravirine: they may diminish the serum concentration of hormonal contraceptive
could potentially lead to a reduction in the concentration serum of Hormonal Contraceptives
could potentially lead to a reduction in the concentration serum of Hormonal Contraceptives
could potentially lead to a reduction in the concentration serum of Hormonal Contraceptives
could potentially lead to a reduction in the concentration serum of Hormonal Contraceptives
When acetohexamide is used together with etravirine, this lead to reduction in acetohexamide’s metabolism
etravirine: they may enhance the serum concentration of CYP2D6 Inhibitors
etravirine: they may enhance the serum concentration of CYP2D6 Inhibitors
etravirine: they may enhance the serum concentration of CYP2D6 Inhibitors
etravirine: they may enhance the serum concentration of CYP2D6 Inhibitors
etravirine: they may enhance the serum concentration of CYP2D6 Inhibitors
etravirine: they may increase the antiplatelet effect of Agents with antiplatelet agent
etravirine: they may increase the antiplatelet effect of Agents with antiplatelet agent
etravirine: they may increase the antiplatelet effect of Agents with antiplatelet agent
etravirine: they may increase the antiplatelet effect of Agents with antiplatelet agent
etravirine: they may increase the antiplatelet effect of Agents with antiplatelet agent
etravirine: it may enhance the serum concentration of HMG-CoA Reductase Inhibitors
etravirine: it may enhance the serum concentration of HMG-CoA Reductase Inhibitors
etravirine: it may enhance the serum concentration of HMG-CoA Reductase Inhibitors
etravirine: it may enhance the serum concentration of HMG-CoA Reductase Inhibitors
etravirine: it may enhance the serum concentration of HMG-CoA Reductase Inhibitors
when both drugs are combined, there may be a high metabolism of paclitaxel  
etravirine decreases the effect of gefitinib by altering the intestinal/ hepatic CYP3A4 enzyme metabolism
it decreases the concentration of hormonal contraceptives in serum
may diminish the serum concentration of each other when combined
may diminish the serum concentration of Hormonal Contraceptives
may diminish the rate of excretion when combined with each other
When etravirine is used together with lomitapide, this leads to an enhancement in lomitapide’s metabolism
may decrease the level by affecting the hepatic enzyme CYP3A4 metabolism
Frequency defined:Â Â Â
>10%Â
Skin rashÂ
Increased serum cholesterol Â
1% to 10%:Â
Angina pectorisÂ
Facial edemaÂ
Myocardial infarctionÂ
SyncopeÂ
Peripheral neuropathyÂ
Abnormal dreamsÂ
AnxietyÂ
ConfusionÂ
DrowsinessÂ
DisorientationÂ
Disturbance in attentionÂ
NervousnessÂ
HypoesthesiaÂ
PrurigoÂ
Night sweatsÂ
XerodermaÂ
Diabetes Â
lipohypertrophyÂ
pancreatitisÂ
stomatitisÂ
anorexiaÂ
constipation Â
flatulence Â
gastritis Â
Post-marketing:Â
AngioedemaÂ
Erythema multiformeÂ
Hemorrhagic strokeÂ
RhabdomyolysisÂ
Stevens-Johnson syndromeÂ
Dress syndromeÂ
Pregnancy consideration: Etravirine transfer across the human placenta.Â
Lactation: Etravirine can be present in breast milk. Â
Pregnancy category:Â
Â
Patient information leafletÂ
Generic Name: Etravirine Â
Pronunciation: etravirine Â
Why do we use Etravirine?Â
It is used to treat viral infections such as HIV-1 infection.